Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. OGI
stocks logo

OGI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
73.02M
+70.88%
-0.007
-95.04%
Estimates Revision
The market is revising No Change the revenue expectations for Organigram Global Inc. (OGI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -0.61%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-0.61%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Organigram Global Inc (OGI.O) is -56.55, compared to its 5-year average forward P/E of -20.34. For a more detailed relative valuation and DCF analysis to assess Organigram Global Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-20.34
Current PE
-56.55
Overvalued PE
-2.46
Undervalued PE
-38.22

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-26.17
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
219.45
Undervalued EV/EBITDA
-271.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.09
Current PS
0.00
Overvalued PS
6.17
Undervalued PS
0.01
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

OGI News & Events

Events Timeline

(ET)
2025-11-25
07:18:22
James Yamanaka Named CEO of Organigram
select
2025-11-25
06:01:47
Organigram appoints James Yamanaka as its new CEO
select
2025-10-21 (ET)
2025-10-21
06:03:29
Organigram Revises CEO Succession Strategy
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
05:00 AMNASDAQ.COM
Cooper Companies (COO) Reports Q4 Earnings and Revenues Exceed Expectations
  • Earnings Performance: The Cooper Companies reported quarterly earnings of $1.15 per share, exceeding the Zacks Consensus Estimate of $1.11, and showing a year-over-year increase from $1.04 per share.

  • Revenue Growth: The company achieved revenues of $1.07 billion for the quarter, surpassing expectations by 0.45% and up from $1.02 billion a year ago.

  • Stock Outlook: Despite the positive earnings report, The Cooper Companies' stock has underperformed the market, with a Zacks Rank of #4 (Sell), indicating expectations of continued underperformance in the near future.

  • Industry Context: The Medical - Dental Supplies industry is currently ranked in the bottom 38% of Zacks industries, which may impact the stock's performance, while investors are also looking ahead to earnings estimates for the upcoming quarters.

[object Object]
Preview
5.0
11-25Newsfilter
Organigram Appoints New CEO James Yamanaka, Effective January 15, 2026
  • Executive Appointment: Organigram announces the appointment of James Yamanaka as the new CEO, effective January 15, 2026, aiming to leverage his extensive international experience to drive the company's global expansion.
  • Strategic Background: With over 20 years at British American Tobacco as Global Head of Strategy, Yamanaka achieved record market share in Japan, showcasing his exceptional capabilities in market development and business transformation, which will provide strategic advantages for Organigram.
  • Interim Management Arrangement: Current Board Chairman Peter Amirault will serve as interim Executive Chair starting December 1, ensuring smooth day-to-day management until Yamanaka assumes his role, reflecting the company's commitment to leadership transition.
  • Future Outlook: Yamanaka expressed excitement about building an international presence on Organigram's strong foundation, emphasizing the company's leading position in the Canadian recreational cannabis market and its commitment to becoming a global industry leader.
[object Object]
Preview
5.0
11-25NASDAQ.COM
James Yamanaka Appointed CEO of Organigram
  • New CEO Appointment: James Yamanaka has been appointed as the new CEO of Organigram Global Inc., effective January 15, 2026, bringing over 20 years of experience from British American Tobacco.

  • Interim Management: Peter Amirault will serve as executive chair on an interim basis starting December 1, overseeing daily operations until Yamanaka takes over as CEO.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Organigram Global Inc (OGI) stock price today?

The current price of OGI is 1.64 USD — it has decreased -2.38 % in the last trading day.

arrow icon

What is Organigram Global Inc (OGI)'s business?

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

arrow icon

What is the price predicton of OGI Stock?

Wall Street analysts forecast OGI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OGI is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Organigram Global Inc (OGI)'s revenue for the last quarter?

Organigram Global Inc revenue for the last quarter amounts to 70.79M USD, increased 72.41 % YoY.

arrow icon

What is Organigram Global Inc (OGI)'s earnings per share (EPS) for the last quarter?

Organigram Global Inc. EPS for the last quarter amounts to -0.05 USD, decreased -266.67 % YoY.

arrow icon

What changes have occurred in the market's expectations for Organigram Global Inc (OGI)'s fundamentals?

The market is revising No Change the revenue expectations for Organigram Global Inc. (OGI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -0.61%.
arrow icon

How many employees does Organigram Global Inc (OGI). have?

Organigram Global Inc (OGI) has 898 emplpoyees as of December 05 2025.

arrow icon

What is Organigram Global Inc (OGI) market cap?

Today OGI has the market capitalization of 220.29M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free